Breaking News

Perrigo, Catalent Win Approval for Generic Albuterol Aerosol

Becomes the first generic Metered-Dose Inhaler to be approved by the FDA in more than twenty years

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The U.S. FDA has approved Perrigo’s abbreviated new drug application for generic albuterol sulfate inhalation aerosol, the first AB-rated generic version of ProAir HFA. Perrigo is launching a limited quantity of generic albuterol sulfate inhalation aerosol and, in collaboration with its development and manufacturing partner Catalent, is ramping up production to meet future demand.   Generic albuterol sulfate inhalation aerosol is indicated for the treatment or prevention of bronchospasm with ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters